After years of patent protection, biosimilars for Humira are set to enter the US market in 2023. The arrival of these drugs has been widely anticipated throughout the healthcare industry.

Novartis' Sandoz division has filed its biosimilar of Humira in the US, aiming to take a share of its multi-billion dollar revenues once its patent expires. The generics and biosimilars arm of ...

AbbVie holds a strong portfolio of marketed and pipeline drugs. While the increasing competition to the company's key drug Humira should slow the growth for the company in the near term ...

If you thought 2024 was popping, you ain’t seen nothing yet. The 2025 Bahrain events calendar features tons of awesome festivals, parties, new openings, and more. You might also like: The ultimate ...

Planning a family adventure and on the hunt for brilliant things to do with kids in Bahrain? The city is dotted with tons of kids’ party venues, fab soft play spots, super large playgrounds for ...

Chronic diseases are the primary reason of death worldwide, per the WHO. For example, cardiovascular disease causes approximately 18.01 million fatalities annually worldwide. In such instances ...